APP and Alzheimer disease: Our study indicates that pathological deficiency of CHCHD6 is an inducer that acts upstream of both APP amyloidogenic processing and neural cholesterol accumulation, which provides a direct mechanistic explanation for the impact of mitochondrial damage on AD neuropathology.